*MDUFA 6 Deficiency Survey

Past New Requirement Updated

Agency
Solicitation expected
Estimated value
$700,000 to $1,500,000
Set-aside
No set-aside

Forecast facts

Anticipated award
NAICS code
Not on record
Points of contact

Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.

About this forecast

The Food and Drug Administration will procure contractor services to develop and execute a deficiency survey for recipients of FDA deficiency letters, with solicitation release estimated for July 1, 2026 and award targeted for January 1, 2027. The contractor will collaborate with FDA to design the survey including questions, conduct methodology, and scoring approach, manage survey execution and results reporting, and ensure Paperwork Reduction Act compliance and approval. Development activities should begin no later than fiscal year 2028.

The estimated award value ranges from $700,000 to $1.5 million. The survey will inform FDA's deficiency improvement activities. Inquiries should be directed to cdhracquisitions@fda.hhs.gov.

Forecast text

The Contractor will (in collaboration with FDA) develop a survey (including questions, conduct, and scoring methodology) for recipients of FDA deficiency letters, manage survey execution and results reporting, and oversee Paperwork Reduction Act (PRA) compliance and approval. The survey's purpose will be to inform FDA's deficiency improvement activities and development should begin NLT FY28.

On GovTribe

Work this forecast

  • Track it in your pipeline
  • Find teaming partners
  • Similar forecasts
  • Ask GovTribe AI about this forecast